Phase II trial of elinogrel in patients with stable coronary artery disease and high platelet reactivity who did not respond to clopidogrel.

Trial Profile

Phase II trial of elinogrel in patients with stable coronary artery disease and high platelet reactivity who did not respond to clopidogrel.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Nov 2008

At a glance

  • Drugs Aspirin; Clopidogrel; Elinogrel
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Sponsors Portola Pharmaceuticals
  • Most Recent Events

    • 11 Nov 2008 Results presented at the American Heart Association's Annual Scientific Sessions 2008.
    • 11 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top